Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007001066) PHARMACEUTICAL PREPARATION CONTAINING AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/001066 International Application No.: PCT/JP2006/313175
Publication Date: 04.01.2007 International Filing Date: 26.06.2006
IPC:
A61K 45/00 (2006.01) ,A61P 9/12 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
12
Antihypertensives
Applicants:
DAIICHI SANKYO COMPANY, LIMITED [JP/JP]; 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426, JP (AllExceptUS)
HAMAURA, Takeshi [JP/JP]; JP (UsOnly)
KANNO, Mitsuru [JP/JP]; JP (UsOnly)
Inventors:
HAMAURA, Takeshi; JP
KANNO, Mitsuru; JP
Agent:
YAGUCHI, Toshiaki ; c/o Daiichi Sankyo Company, Limited 1-16-3, Kitakasai Edogawa-ku Tokyo 134-8630, JP
Priority Data:
2005-18725127.06.2005JP
Title (EN) PHARMACEUTICAL PREPARATION CONTAINING AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER
(FR) PRÉPARATION PHARMACEUTIQUE CONTENANT UN ANTAGONISTE DU RÉCEPTEUR DE L'ANGIOTENSINE II ET UN BLOQUEUR DU CANAL CALCIQUE
Abstract:
(EN) The invention relates to a pharmaceutical preparation comprising an angiotensin II receptor antagonist, a calcium channel blocker and at least one substance selected from a hydrophilic polymer, an acidic substance and a fluidizing agent. The pharmaceutical preparation demonstrates improved dissolution properties.
(FR) L'invention concerne une préparation pharmaceutique qui comprend un antagoniste du récepteur de l'angiotensine II, un bloqueur du canal calcique et au moins une substance choisie parmi un polymère hydrophile, une substance acide et un agent fluidisant. La préparation pharmaceutique présente des propriétés de dissolution améliorées.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
KR1020080016801EP1898951BRPI0612674-0JP2008543728US20080279942US20090306151
US20110281823CN101247832CA2613417ES2404939KR1020130135994BRPI0612674